Cost of Gram-negative resistance*
- 1 January 2007
- journal article
- research article
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 35 (1) , 89-95
- https://doi.org/10.1097/01.ccm.0000251496.61520.75
Abstract
Objective: It is unclear that infections with Gram-negative rods resistant to at least one major class of antibiotics (rGNR) have a greater effect on patient morbidity than infections caused by sensitive strains (sGNR). We wished to test the hypothesis that rGNR infections are associated with higher resource utilization. Design: Retrospective observational cohort study of prospectively collected data. Setting: University hospital surgical intensive care unit and ward. Patients: Surgical patients with at least one GNR infection. Measurements: We compared admissions treated for rGNR infection with those with sGNR infections. Primary outcomes were total hospital costs and hospital length of stay. Other outcomes included antibiotic treatment cost, in-hospital death, and intensive care unit length of stay. After univariate analysis comparing outcomes after rGNR infection with those after sGNR infection, multivariate linear regression models for hospital cost and length of stay were created to account for potential confounders. Main Results: Cost data were available for 604 surgical admissions treated for at least one GNR infection (Centers for Disease Control and Prevention criteria), 137 (23%) of which were rGNR infections. Admissions with rGNR infections were associated with a higher severity of illness at the time of infection (Acute Physiology and Chronic Health Evaluation II score, 17.6 ± 0.6 vs. 13.9 ± 0.3), had higher median hospital costs ($80,500 vs. $29,604, p < .0001) and median antibiotic costs ($2,607 vs. $758, p < .0001), and had longer median hospital length of stay (29 vs. 13 days, p < .0001) and median intensive care unit length of stay (13 days vs. 1 day, p < .0001). Infection with rGNR within the first 7 days of admission was independently predictive of increased hospital cost (incremental increase in median hospital cost estimated at $11,075; 95% confidence interval, $3,282–$20,099). Conclusions: Early infection with rGNR is associated with a high economic burden, which is in part related to increased antibiotic utilization compared with infection with sensitive organisms. Efforts to control overuse of antibiotics should be pursued.Keywords
This publication has 36 references indexed in Scilit:
- The Impact of Methicillin Resistance in Staphylococcus aureus Bacteremia on Patient Outcomes: Mortality, Length of Stay, and Hospital ChargesInfection Control & Hospital Epidemiology, 2005
- Effect of Nosocomial Vancomycin-Resistant Enterococcal Bacteremia on Mortality, Length of Stay, and CostsInfection Control & Hospital Epidemiology, 2003
- Impact of antibiotic-resistant Gram-negative bacilli infections on outcome in hospitalized patientsCritical Care Medicine, 2003
- Adverse Clinical and Economic Outcomes Attributable to Methicillin Resistance among Patients withStaphylococcus aureusSurgical Site InfectionClinical Infectious Diseases, 2003
- Antibiotic Resistance Among Gram-Negative Bacilli in US Intensive Care UnitsJAMA, 2003
- Reappraisal of attributable mortality in critically ill patients with nosocomial bacteraemia involving Pseudomonas aeruginosaJournal of Hospital Infection, 2003
- Temporal Changes in Prevalence of Antimicrobial Resistance in 23 U.S. HospitalsEmerging Infectious Diseases, 2002
- Nosocomial Bacteremia Caused by Antibiotic‐Resistant Gram‐Negative Bacteria in Critically Ill Patients: Clinical Outcome and Length of HospitalizationClinical Infectious Diseases, 2002
- Vancomycin-sensitive and vancomycin-resistant enterococcal infections in the ICU: attributable costs and outcomesIntensive Care Medicine, 2002
- Increasing antimicrobial resistance in gram-negative bacilli isolated from patients in intensive care unitsAmerican Journal of Infection Control, 2000